Concord Wealth Partners’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $535 | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $517 | Sell |
|
|||||
|
2024
Q2 | $1.08K | Sell |
|
|||||
|
2024
Q1 | $2.11K | Buy |
|
|||||
|
2023
Q4 | $1.25K | Sell |
|
|||||
|
2023
Q3 | $7.22K | Sell |
|
|||||
|
2023
Q2 | $16K | Buy |
|
|||||
|
2023
Q1 | $9.9K | Sell |
|
|||||
|
2022
Q4 | $53.5K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $175K | Buy |
|
|||||
|
2022
Q1 | $75K | Buy |
|
|||||
|
2021
Q4 | $60K | Buy |
|
|||||
|
2021
Q3 | $24K | Sell |
|
|||||
|
2021
Q2 | $89K | Sell |
|
|||||
|
2021
Q1 | $70K | Buy |
|